Castlight Health Inc. (NYSE:CSLT) CRO John Mccracken sold 99,371 shares of the business’s stock in a transaction on Wednesday, November 16th. The stock was sold at an average price of $5.02, for a total value of $498,842.42. Following the transaction, the executive now directly owns 67,591 shares of the company’s stock, valued at approximately $339,306.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

John Mccracken also recently made the following trade(s):

  • On Friday, November 18th, John Mccracken sold 5,570 shares of Castlight Health stock. The stock was sold at an average price of $4.81, for a total value of $26,791.70.
  • On Tuesday, November 15th, John Mccracken sold 46,008 shares of Castlight Health stock. The stock was sold at an average price of $5.01, for a total value of $230,500.08.
  • On Monday, November 14th, John Mccracken sold 31,780 shares of Castlight Health stock. The stock was sold at an average price of $5.00, for a total value of $158,900.00.
  • On Thursday, August 18th, John Mccracken sold 5,594 shares of Castlight Health stock. The stock was sold at an average price of $4.13, for a total value of $23,103.22.

Shares of Castlight Health Inc. (NYSE:CSLT) opened at 4.75 on Monday. The company’s market cap is $492.59 million. The company’s 50 day moving average price is $4.17 and its 200 day moving average price is $4.10. Castlight Health Inc. has a 12 month low of $2.54 and a 12 month high of $5.10.

Castlight Health (NYSE:CSLT) last issued its quarterly earnings data on Wednesday, November 2nd. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.04. Castlight Health had a negative return on equity of 58.57% and a negative net margin of 73.57%. The company had revenue of $25.50 million for the quarter, compared to the consensus estimate of $24.81 million. During the same quarter last year, the business posted ($0.17) earnings per share. The firm’s revenue was up 30.8% compared to the same quarter last year. On average, equities analysts expect that Castlight Health Inc. will post ($0.34) EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

Several large investors have recently modified their holdings of the company. Bank of Montreal Can increased its stake in Castlight Health by 4,752.0% in the third quarter. Bank of Montreal Can now owns 24,260 shares of the company’s stock worth $101,000 after buying an additional 23,760 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new stake in Castlight Health during the third quarter worth $132,000. Rhumbline Advisers increased its stake in Castlight Health by 2.1% in the third quarter. Rhumbline Advisers now owns 32,087 shares of the company’s stock worth $133,000 after buying an additional 650 shares during the last quarter. Metropolitan Life Insurance Co. NY purchased a new stake in Castlight Health during the second quarter worth $136,000. Finally, Stifel Financial Corp increased its stake in Castlight Health by 40.9% in the second quarter. Stifel Financial Corp now owns 38,330 shares of the company’s stock worth $152,000 after buying an additional 11,130 shares during the last quarter. Institutional investors own 50.75% of the company’s stock.

A number of brokerages recently weighed in on CSLT. FBR & Co restated a “hold” rating and set a $4.00 price objective on shares of Castlight Health in a research report on Wednesday, August 10th. Morgan Stanley restated a “hold” rating and set a $4.00 price objective on shares of Castlight Health in a research report on Thursday, August 25th. Zacks Investment Research upgraded Castlight Health from a “hold” rating to a “buy” rating and set a $5.00 price objective on the stock in a research report on Friday, August 12th. Finally, Canaccord Genuity restated a “hold” rating and set a $5.00 price objective on shares of Castlight Health in a research report on Sunday, September 11th. Six analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $4.58.

Castlight Health Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families.

5 Day Chart for NYSE:CSLT

Receive News & Stock Ratings for Castlight Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc. and related stocks with our FREE daily email newsletter.